The features of the chemistry of 4-thiazolidinone and pyrazole/pyrazolines as pharmacologically attractive scaffolds were described in a number of reviews in which the main approaches to the synthesis of mentioned heterocycles and their biological activity were analyzed. However, the pyrazole/pyrazoline ethiazolidine-based hybrids as biologically active compounds is poorly discussed in the context of pharmacophore hybrid approach. Therefore, the purpose of this review is to summarize the data about the synthesis and modification of heterocyclic systems with thiazolidine and pyrazoline or pyrazole fragments in molecules as promising objects of modern bioorganic and medicinal chemistry. The description of biological activity was focused on SAR analysis and mechanistic insights of mentioned hybrids.
Introduction
Pharmacophore hybrid approach is a current concept in drug design and development to produce molecules with improved affinity and efficacy. There are some reviews dealing with the concept of molecular hybridization and the promises/challenges associated with these hybrid molecules along with recent advances on anticancer hybrids [1e3] . Various heteroaryl based hybrids in particular isatin and coumarins [3] or indoline-thiazolidinones [4] have been recently reviewed as conjugates with remarkable inhibitory potential.
Design of new drug-like small molecules based on the pharmacologically attractive scaffolds of thiazolidine (4-thiazolidinone) [5e10] and pyrazole or pyrazoline [11e15] is a reasonable and promising direction in modern medicinal chemistry. The chemical approaches for the synthesis of thiazolidinone-and pyrazole-based derivatives and their pharmacological activity were described in a numerous reviews [5e12]. However, the pyrazole/pyrazolineethiazolidine-based conjugates as biologically active compounds are poorly reviewed in the context of pharmacophore hybrid approach.
The recent synthetic studies of pyrazoleethiazolidines and related hybrids and biological investigations for their antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory activities allowed to identify the promising drug-like compounds. Thus, the pyrazoleethiazolidinones/thiazoles have been patented as inhibitors of necroptosis [16] , VHR protein tyrosine phosphatase inhibitors [17] , Pin1-modulating compounds [18] , compounds for modulating RNA-binding proteins [19] and activators of proapoptotic BAX [20] . In addition, the pyrazoleethiazolidinone hybrids have been studied for their possibility to inhibit the TNF-aeTNFRc1 interaction [21] , as inhibitors of histone acetyltransferases [22] and inhibitors of COX [31, 39] and ADAMTS-5 enzymes [83] . Therefore, the purpose of this review is to summarize the data about the synthesis and biological activity of heterocyclic systems with thiazolidine and pyrazole/pyrazoline fragments in molecules. The most promising pyrazoleethiazolidinone/thiazole hybrids and target heterocycles that have been reviewed as fragments of hybrid molecules are depicted in Fig. 1 .
The reviewed hybrids were classified as 2-, 3-and 5-pyrazole/ pyrazoline-substituted thiazolidines based on linkage of target heterocyclic cores. The basic approaches for the synthesis of mentioned derivatives provide a combination of two "small" molecules in aminolysis reactions, acylation and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2þ3]cyclization reaction yielding the series of non-condensed bicyclic systems.
Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2
Detailed biological activity evaluation of pyrazolineethiazolidinone conjugates 1.2e1.7 and pyrazolineethiazoles 1.8, 1.9 (Fig. 2) , synthesized via the [2þ3]cyclocondensation of 4,5-dihydropyrazole-1-carbothioamides 1.1 as S,N-binucleophiles in reactions with equivalents of dielectrophilic synthon [C2] 2þ , allowed to identify compounds with antimicrobial [23e28], antiviral [29, 30] , anti-inflammatory [31] , antitumor [32e35] and insecticidal [36] activities. For synthesis of target derivatives a-halogenocarboxylic acids [31, 33] and their ethyl esters [23e29, 35, 36] , maleic anhydride [30] , maleimides [30, 38] , b-aroylacrylic acids [30] , dimethyl acetylenedicarboxylate [37] , bromoacetophenones [23, 24, 28, 29, 35] and ethyl 4chloroacetoacetate [35] were used as equivalents of dielectrophilic synthon [C2] 2þ .
Three-component one-pot reaction that includes [2þ3]cyclocondensation of 4,5-dihydropyrazole-1-carbotioamides 1.1 with chloroacetic acid and the further Knoevenagel reaction with aromatic aldehydes [33, 34] and isatin derivatives [32] is an effective approach for design of new anticancer agents among the pyrazolineethiazolidinones 1.10, 1.11 (Fig. 3) .
The reaction between pyrazolyl-imines [39, 40] or pyrazolylhydrazones [41] and thioglycolic acid or its esters is widely used approach for the synthesis of 4-thiazolidinone conjugates 1. 12, 1.13 RNA binding proteins modulator [19] Pro-apoptotic BAX activator [20] TNF-a inhibitor [21] with pyrazole moiety in position 2. A. Khodairy proposed a synthesis of 2-substituted 4-thiazolidinone with benzopyrano [2,3-c] pyrazol-3-one fragment 1.14, using N-cyanoacetyl-benzopyranopyrazolone [42] as a starting compound ( Fig. 4 ).
Another direction for synthesis of pyrazole-substituted thiazoline 1.16 ( Fig. 5 ) was realized by the creation of pyrazole moiety via the reaction between 5-fluoro-2-hydrazino-4-hydroxy-4,5bis(trifluoromethyl)-1,3-thiazoline 1.15 with acetoacetone [43, 44] .
A broad group of pyrazoleethiazolidinone derivatives exemplified by 2-imino-4-thiazolidinones (pseudothiohydantoines) 1.18, 1.19 were synthesized via [2þ3]-cyclocondensation of pyrazole substituted asymmetric bis-thioureas 1.17 as S,N-binucleophiles with some equivalents of dielectrophilic synthon [C2] 2þ (ethyl 2chloroacetate [45, 46] , dimethyl acetylenedicarboxylate [47] ). Simultaneously, bioisosteric pyrazolyl-2-iminothiazolidines 1.20 [46] were obtained by reaction of thioureas 1.17 with a-bromoacetophenones ( Fig. 6 ).
Aiming to search for new anticancer or antimicrobial compounds among pyrazoleethiazolidinone conjugates the pyrazolesulfonyl-thioureas 1.21 were used as starting materials. The reaction between compounds 1.21 and ethyl 2-chloroacetate or abromoacetophenone resulted in formation of the corresponding pyrazoleethiazolidinones 1.22 and pyrazole-thiazolidines 1.23 with sulfonylimine linker group [48e53] ( Fig. 7) .
Another approach for the synthesis of pyrazole derivatives of pseudothiohydantoin 1.26 was suggested by B. Insuasty et al. [54] . The synthesis of target compounds was carried out via aminolysis of 5-arylidene-2-thioxo-4-thiazolidinones (5-arylidenerhodanines) 1.24 by 4,5-diaminopyrazoles 1.25 ( Fig. 8) .
A row of 2-pyrazolyl-hydrazoneethiazolidinones 1.28e1.30 was synthesized via [2þ3]-cyclocondensation of thiosemicarbazones 1.27 with a-halogenocarboxylic acids derivatives or maleic anhydride [55e60]. The pyrazole with bioisosteric 2-thiohydantoin 1.31 [61] and thiazolidine 1.32 [55e60] fragments were obtained by reaction of thiosemicarbazones 1.27 with chloroacetic acid in pyridine or a-bromoacetophenone. However, the reaction of thiosemicarbazones 1.27 with acetic anhydride or iron chloride was accompanied by the formation of pyrazoleethiadiazole derivatives 1.33, 1.34 [56] (Fig. 9 ).
Pyrazole-substituted thiosemicarbazides 1.35 were used for synthesis of the pyrazoleethiazolidinones 1.36 with carbohydrazide linker group [62, 63] . The three-component one-pot reaction between thiosemicarbazides 1.35, chloroacetic acid and aromatic aldehydes accompanied by formation of the corresponding 5-arylidene-4-thiazolidinones 1.37 [63, 64] . The modification of 1.35 in sulfuric acid medium gave pyrazoleethiadiazole 1.38 [64] . The reaction of compounds 1.35 with a-bromoacetophenones was accompanied by the formation of corresponding pyrazole-thiazolidine conjugates 1.39 [62e64] ( Fig. 10 ).
The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3
Synthesis of 2-diazole-substituted 4-thiazolidinones was achieved via the [2þ3]-cyclocondensation of the pyrazole-based asymmetric thioureas 1.17 as S,N-binucleophiles (see Fig. 6 ). At the same time, the numerous papers represent the data about obtaining of 4-thiazolidinones with diazole moiety in 3 position (compound 2.1, Fig. 11 ), in particular via the reaction of thioureas with ethylchloroacetate [65] .
The dithiocarbamate method of 2-thioxo-4-thiazolidinones (rhodanines) synthesis is a convenient and often used variant of the synthesis of 4-thiazolidinone derivatives based on the [2þ3]cyclocondensation [5] . R.M. Mohareb et al. had successfully applied the dithiocarbamate method for the synthesis of 3-(pyrazol-5-yl)-2-thioxo-4-thiazolidinone via two-stage process based on the reaction between 3-phenyl-5-aminopyrazole 2.2 and carbon disulfide in an alkaline medium and subsequent cyclization with Various 4-thiazolidinones were synthesized by reaction of amercaptocarboxylic acids (especially thioglycolic acid) with isothiocyanates (ReN]C]S). Thus, a pyrazoleethiazolidinone 2.8 with phenyl sulfonamide linker group was obtained based on the mentioned approach [67] . There were described the synthesis of 3pyrazole-substituted or polyheterocyclic derivatives of 4thiazolidinones 2.9, 2.10 based on the reaction between thioglycolic acid and corresponding imines and methylidenehydrazydes or three-component reaction involving thioglycolic acid, aromatic aldehydes and heterocyclic amines containing diazole fragment [68e72]. The reaction of isatin with heterocyclic amines led to Schiff's bases which were further reacted with thioglycolic acid to form 3-diazole-substituted indoline-spirothiazolidinones 2.11 [73, 74] (Fig. 13 ).
The reaction between trithiocarbonyl diglycolic acid and amines in alcohol or alcoholewater medium (Holmberg synthesis) is a convenient and effective method for synthesis of 3-substituted rhodanines, especially based on the aromatic amines and carboxylic acid hydrazides [5] . The mentioned reaction was used by Augustin M. et al. for synthesis of rhodanine 2.12 with benzopyrazole fragment in position 3 [75] (Fig. 14) . The method for synthesis of pyrazoleethiazolidinone 2.15 ( Fig. 15 ) with acetamide linker group was proposed based on the reaction of 5-arylidenerhodanine-3-acetic acid 2.13 and 5aminopyrazole 2.14 in DMF in the presence of HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3oxid hexafluorophosphate) [76] .
Synthesis of structurally related azolidineepyrazolines 2.16, 2.17 was proposed based on N-alkylation reaction of potassium salts of 2,4-thiazolidinedione, hydantoin and their 5-arylidene derivatives, obtained in situ ( Fig. 16 ). 2-Chloro-1-(3,5-diarylpyrazolin-1-yl)ethanones were successfully used as alkylating agents [77] .
The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5
One of the main approaches for the synthesis of 5-pyrazole/ pyrazoline substituted 4-thiazolidinones is based on Knoevenagel reaction of 4-thiazolidinones [5] . successfully modified in diazo coupling reaction [91] using pyrazolyl diazonium chloride yielding compound 3.3 (Fig. 17 ).
The synthesis of pyrazolineeindolineethiazolidinone conjugates 3.5, 3.6 was realized by the Knoevenagel reaction of pyrazolineeisatines 3.4 with 2,4-thiazolidinedione, 2-thioxo-4thiazolidinone and 2-amino-4-thiazolidinone in the acetic acid medium and in the presence of sodium acetate [92] (Fig. 18 ).
The synthesis of pyrazoloneethiazolidinones 3.7 ( Fig. 19 ) was achieved based on the reaction between isonitrosorhodanines and 5-methyl-2,4-dihydropyrazol-3-one using piperidine as basic catalyst [93] .
Magdy allowed to obtain the corresponding pyrazole-thiazolidinones 3.9 [94] . Using hydrazine hydrate the structure of final compounds depended on the reaction medium. Thus, 1N-non-substituted pyrazoles were obtained in alcohol medium and in the presence of sodium ethylate, while 1N-acetylderivatives were formed in acetic acid. The reaction of the compound 3.8 and 1-phenylpyrazolidin- 3,5-dione in the presence of sodium ethylate led to formation of polyheterocyclic system 3.10 ( Fig. 20) .
Synthesis of 5-pyrazolyl-4-thiazolidinones with ethylene linker group 3.11 was performed via the [2þ3]-cyclocondensation reaction of thiourea with g-pyrazolyl-a-chlorobutanoates [95] (see Pharmacologically attractive 5-(5-oxo-4,5-dihydro-1H-pyrazol-4-yl)rhodanines 3.12 ( Fig. 22 ) were synthesized following heterocyclization of 2-thiazolidinyl-3-oxobutanoates with phenylhydrazine or conjugation of 4-bromopyrazolon-5-ones to 3arylrhodanines [96] .
The group of pyrazolineethiazolidinones 3.13 was obtained by reaction of 5-bromo-2,4-thiazolidindione with 3,5diarylpyrazolines in alcohol medium (Fig. 23 ). The synthesized compounds were modified in position 3 of thiazolidine cycle by Mannich reaction with secondary cyclic amines and alkylation reactions forming 3.14, 3.15 [97] .
The following approach to the synthesis of pyrazolineethiazolidinone conjugates 3.16 with carbonyl methylidene linker group was based on the acylation reaction of 3,5diarylpyrazolines ( Fig. 24 ). The further reaction of substances 3.16 with chloroacetamides via N-alkylation reaction led to derivatives 3.17 [97] .
To explore the structure-antitrypanosomal activity relationship the pyrazolineethiazolidinone conjugates 3.18 were synthesized through the reaction of the 5-ethoxymethylidenerhodanines with 3,5-diarylpyrazolines ( Fig. 25 ). 5-Pyrazoline substituted 4-thioxo-2-thiazolidinones 3.19 were obtained under the same conditions [98] .
To continue the above mentioned study, 5-pyrazoline derivatives of 4-thiazolidinone 3.21 with oxoethylamino-methylene linker group were synthesized by modification of rhodanine-5carboxylic acid 3.20 in the reaction with pyrazolines and in the presence of DCC (dicyclohexylcarbodiimide) [98] (Fig. 26 ).
Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids

Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids
Antitumor activity evaluation is promising for the thiazolidinones with pyrazoline fragment. The in vitro anticancer activity of thiazolidinones with pyrazoline cycle in position 2 (4.2) or 4 (4.3) of thiazolidine was tested by the National Cancer Institute (NCI) and most of them displayed anticancer activity on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate and breast cancers cell lines. The most efficient anticancer compound 4.1 was found to be active with selective influence on colon cancer cell lines, especially on HT 29 (lgGI 50 ¼ À6.37) [33] . The SAR study revealed that: (1) anticancer activity of compounds is sensitive to the nature of substituent in position 5 of thiazolone cycle, (2) introduction of p-OH group in 5-benzylidene fragment enhanced potency, and (3) the positional isomers, namely 2-pyrazoline (4.2) and 4-pyrazoline (4.3) substituted thiazolones are promising compounds for further optimization (Fig. 27 ).
Novel pyrazolineethiazolidinoneeisatin 4.4 and pyrazoleindoline-2-one 4.5 conjugates were designed as potential anticancer agents (Fig. 28 ). The most effective anticancer compound 4.6 was found to be active with a mean GI 50 and TGI values of 0.071 mM and 0.76 mM, respectively and demonstrated the highest antiproliferative influence on the non-small cell lung cancer cell line HOP-92 (GI 50 < 0.01 mM), colon cancer line HCT-116 (GI 50 ¼ 0.018 mM), CNS cancer cell line SNB-75 (GI 50 ¼ 0.0159 mM), ovarian cancer cell line NCI/ADR-RES (GI 50 ¼ 0.0169 mM) and renal cancer cell line RXF 393 (GI 50 ¼ 0.0197 mM). The SAR study revealed that: (1) potent anticancer activity of tested compounds depended on the presence of a combination of three heterocycles in one molecule, thus the pyrazolineethiazolidinoneeisatin conjugates were more active in comparison with pyrazolineethiazolidinone or pyrazole-indoline-2-one systems; (2) attachment of halogen (Br or Cl) to 5-position of isatin scaffold allowed to gain one log unit of activity (GI 50 level), in comparison with 5-unsubstituted isatin analogs; (3) introduction of a methyl group or CH 2 COOH group at 1N-position of isatin fragment led to the loss of activity; (4) the nature of a substituent in the 5-aryl fragment also had an influence on the antitumor activity. Therefore, the introduction of electron-withdrawing group e 4chlorine improved the antiproliferative activity in comparison with electron-donor 2-OH, 4-OMe and 4-NMe 2 groups. This would indicate that decreased of electron density on 5-aryl moiety is important for the inhibitory activity; and (5) substitution of the phenyl fragment in 3 position of pyrazoline cycle on naphthalene-2-yl substituent did not have significant influence on antitumor activity, but introduction of the 4-methoxyphenyl group in the mentioned position limited this effect [32] . method. As a result of studies two hit-compounds 4.10 and 4.11 were selected. SAR analysis showed that the determining factor for expression of antitumor activity is the structure of the substituent in the 4 position of thiazole ( Fig. 29) . A modification of the ester group into hydrazide and, subsequently, a hydrazone gave the potentiation of antitumor properties. At the same time, pyrazolineethiazolidinones 4.9 had no significant cytotoxicity [35] .
The series of pyrazolineethiazolidine-based compounds were tested for antitumor activity according to standard NCI protocol and and thiazolidine (4.20) fragments for screening of antitumor activity on lines: HEPG2 (liver carcinoma cell line) and HELA (cervix carcinoma cell line). Interestingly, each of these compounds showed selective effect on one of the lines similar to 5-fluorouracil ( Fig. 31 ).
Positions for optimization
Synthesis and study of antitumor activity of pyrazole-thiazolidinoneetriazoles on lung cancer MCF-7 line were conducted by Arun M. Isloor et al. [40] . Among the studied conjugates the compound 4.21 was the most active with the effective concentration IC 50 ¼ 22 mg/mL. The presence of o-tolyl fragment was most favorable for the anticancer effect, while substitution with naphthyl ring caused complete loss of activity ( Fig. 32 ).
An important achievement in the study of anticancer pyrazolethiazolidinone hybrid compounds is the establishing of the necroptosis inhibition for pseudothiohydantoin derivatives with pyrazole moiety in 5 position (Fig. 33 ). Among these derivatives a potential inhibitor Necrostatin-7 (Nec-7) was identified with the activity index of 10.6 mM. Further studies aiming to optimize of Nec-7 molecule, were focused on the modification of thiazole fragment, replacement of substituents in the phenyl ring and replacement of pyrazole cycle by other heterocycles. It was established that the replacement of thiazole fragment by the 1,3,4-thiadiazole led to the complete loss of activity. The introduction of the methyl group in The study of antitumor activity for pyrazole-rhodanines allowed to identify the compound 4.25, which proved effective inhibitory effect on the most of the 60 tumor lines at micromolar concentrations according to NCI protocol (Fig. 34) . The substance 4.25 was characterized by a selective effect on leukemia and lung cancer cell lines e especially on HOP-92 (lung cancer) with the values of effective concentration and cytotoxicity GI 50 ¼ 0.62 mM and LC 50 > 100 mM, respectively [82] .
Manal Sarkis et al. carried out the synthesis of new bisthiazolone derivatives as potential inhibitors of CDC25V phosphatase (specified enzyme involved in cell cycle progression and unregulated tumor development). Aiming to investigate the selectivity, the affinity of the compounds was studied to PTP1B (Protein Tyrosine Phosphatase 1B) and VHR (Vaccinia virus H1 Related e a dual-specificity phosphatase). Overall 31 compounds from bis-thiazolidinone group were synthesized and most of them displayed inhibitory activity with micromolar IC 50 values lower than the corresponding monomers. Mentioned group of the compounds included the thiazolidinoneeindazole conjugate 4.26 (Fig. 35) . It was established that the replacement of a 4hydroxyphenyl fragment with indazole was accompanied by selective inhibition of CDC25B phosphatase and loss of PTP1B inhibitory activity (abolished PTP1B inhibition) [99] .
Screening of in vitro antitumor activity for 5-pyrazoline had a moderate activity, but two compounds were identified with selective effect on leukemia cell lines with effective concentration GI 50 2.12e4.58 mM (4.29) and 1.64e3.20 mM (4.30). SAR analysis showed that the introduction of the linker group between heterocycles promoted the potentiation of antitumor activity, however, modification of 3N-position of thiazolidinone cycle via Mannich reaction and alkylation was not effective approach to optimization of hit-compounds ( Fig. 36 ).
Antimicrobial and antifungal activity of pyrazolineethiazolidinones
The search for new antimicrobial and antifungal agents among pyrazolineethiazolidinone related conjugates is a promising direction for biological testing of mentioned compounds. Mervat M. El-Enany et al. synthesized the group of 4-thiazolidinones and thiazoles with pyrazoline fragment in 2 position and studied their antimicrobial activity against Gram-positive (Staphylococcus aureus, Bacillus subtilis), gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and fungi Candida albicans [24] . However, the compound 4.31 was inactive to any of the microorganisms, while activity of 4.32 on B. subtilis appeared commensurate with Amoxacillin and Propenicillin (Fig. 37 ). The research of Bakr F. of microorganisms with MIC values range ¼ 50e500 mg/mL [25] .
Abdel
However, among the above groups of compounds 4.38 could be selected, which showed 2e8 times higher bactericidal activity in experiment than Ampicillin and was twice active than Griseofulvin on fungi. The mentioned compound showed the highest activity with the value of MIC 12.5 mg/mL to P. aeruginosa (Fig. 37 ).
C.S. Reddy et al. performed the synthesis and study of antimicrobial activity of thiazolidinoneepyrazoles 4.39 against the B. subtilis, S. aureus, E. coli and S. pyogenes. It was established the moderate effect of mentioned compounds (MIC ¼ 6.25e50 mg/mL) ( Fig. 38 ). The introduction of chlorine, nitro or hydroxyl groups in the para-position of the benzene ring resulted in 2e4 fold potentiation of activity in comparison to 3-phenyl-4-thiazolidinones. However, replacement of the phenyl moiety to pyridine (4.40) or pyrimidine was particularly effective, which allowed to get 4e8 fold enhance of efficiency [100] .
The pyrazoleethiazolidinones 4.41 or pyrazoleethiazoles 4.42, coupled by hydrazone linker group were investigated as promising agents with antimicrobial and antifungal activity. It was found that the compound 4.41b (R ¼ Me) showed comparable activity (MIC ¼ 25 mg/mL) with Ampicillin against E. coli, and the compound 4.41c (R ¼ Cl) appeared to be the most active on C. albicans (MIC ¼ 12.5 mg/mL) ( Fig. 39) . Overall, pyrazole-thiazolidinones 4.41 had higher activity than related pyrazole-thiazoles 4.42 [60] . Adnan A. Bekhit et al. synthesized the pyrazolineethiazoles and thiazolidinones with sulfanilamide group. Among the studied pyrazolethiazolidinones 4.43 and pyrazoleethiazoles 4.44 the compounds 4.43b (R ¼ Me) and 4.44a (R ¼ H) (Fig. 39 ) were most effective against E. coli (MIC ¼ 25 mg/mL) [56] .
The study of wide range of antimicrobial and antifungal activities of new benzofuranylepyrazoles with thiazolidinone fragment was conducted by Bakr F. Abdel-Wahab et al. The compound 4.45 showed activity against C. albicans and B. subitilis, and thiazolederivative 4.46 was effective against the E. coli [62] (Fig. 40) . To continue the research of pyrazole derivatives with different heterocycles, authors conducted the synthesis of new derivatives of pyrazole with thiophene fragment 4.47e4.49, including pyrazolethiazolidine 4.50 (Fig. 40) and offered a wide range of biological studies, including the evaluation of antimicrobial activity against the following microorganisms: S. aureus ATCC 29213, B. subtilis ATCC6633, Salmonella typhi, Enterobacter Cloaca ATCC3047, K. peneumoniae ATCC13883, P. aeroginosa ATCC27953, E. coli ATCC 25922, Enterococcus faecalis ATCC29212, Mycobacterium phlei, S. cervesiae and C. albicans NRRL Y-477. Among the tested compounds 4.47 and 4.49 showed hihg/good or moderate efficiency against all strains of microorganisms. While compound 4.48 had proved to be the most effective on E. faecalis (MIC ¼ 83.3 mg/mL), compound 4.50 was effective bactericidal agent on the strain S. aureus (MIC ¼ 20.8 mg/mL) and showed significant antifungal effect on S. cervesia (MIC ¼ 41.6 mg/mL) [58] .
Evaluation of antimicrobial activity for thiazolidines with 5pyrazolone fragment 4.51e4.53 (Fig. 41) revealed their effectiveness on B. subtilis NCTC 10400, S. aureus ATCC 25923, E. coli ATCC 25922, P. aeruginosa ATCC 10415) and fungi C. albicans TMRU 3669, A. niger ATCC 6265 [57] .
An antimicrobial screening was carried out for 3-pyrazolinyl-4thiazolidinones against gram-positive bacteria S. aureus MTCC096, B. subtilis MTCC 441 and Staphylococcus epidermis MTCC435, gramnegative bacteria E. coli MTCC 443, P. aeruginosa MTCC 424, S. typhi MTCC 733 and K. pneumoniae MTCC 432, and antifungal effect was studied on A. niger MTCC 282, Aspergillus fumigatus MTCC 343, Aspergillus flavus MTCC 277 and C. albicans MTCC 227. In general the tested compounds ( Fig. 42) showed promising antimicrobial activity. However, it could be emphasized that the bis-spiroindolones 4.55 showed better growth inhibition compared with compounds 4.54 [101] . The compounds with furane and 4-dimethylaminophenyl-groups in position 2 of thiazolidinone showed a higher or comparable efficacy (MIC ¼ 14e22 mg/mL) to Fluconazole [72] .
Among 5-pyrazolyl-4-thiazolidinones the compounds 4.57 (Fig. 44) were investigated for their antimicrobial activity. The most effective pyrazole-thiazolidinones included the 4-Br-phenyl or thiophene fragments in molecules and showed 2e4 times higher efficiency (MIC ¼ 16e31 mg/mL) in comparison with other derivatives [80] . The moderate antimicrobial activity towards E. coli and S. aureus was identified for 3N-glycoside substituted 2-thioxo- 4-thiazolidinone derivatives 4.58 (Fig. 44 ). The p-bromophenyl substituted derivative showed the highest efficiency against E. coli (MIC ¼ 143 mg/mL) but was 3 times less active than tetracycline (MIC ¼ 39 mg/mL) [84] .
However, the most promising group of antimicrobial agents is 5pyrazolylrhodanines 4.59e4.63 [85, 86, 102, 103] . Antimicrobial activity of these substances was studied against methicillin-(MRSA) and quinolone-resistant (QRSA) S. aureus. Compounds 4.59e4.61 exhibited stronger activity than the standard drugs, norfloxacin and oxacillin, with MIC values of 1e2 mg/mL. SAR analysis for pyrazolerhodanine derivatives 4.62, 4.63 revealed the importance of aryl moiety presence in the pyrazole ring for expression of antimicrobial action and a number of substituents that considerably increased effectiveness were identified (Fig. 45 ).
Antiviral and antiparasitic activity of pyrazoleethiazolidinone hybrids
The search for new chemotherapeutic agents among pyrazoleethiazolidinones is not limited by anticancer and antimicrobial studies. The evaluation of antiviral and antiparasitic activities for mentioned hybrid compounds allowed identifying promising hit-compounds and conducting SAR analysis. Osama I. El-Sabbagh proposed the synthesis of a group of pyrazolineethiazolidinones 4.64 and structurally related pyrazolineethiazoles 4.65 ( Fig. 46 ) and performed a study of a wide range of antiviral activity. It should be noted that described compounds showed selective activity. However, one derivative (Ar ¼ 4-Me-C 6 H 4 ) among compounds 4.64 had moderate efficacy against herpes simplex virus type 1, herpes simplex virus type 2, vaccinia virus, vesicular stomatitis virus and thymidine kinase-deficient herpes simplex virus type 1 with value of the effective concentration of 4 mg/mL and cytotoxicity value 20 mg/ mL (SI ¼ 5) [29] .
Study of thiazolidinones with sulfonamide fragment against the hepatitis C virus, conducted by Yili Ding et al. allowed to identify a number of promising antiviral agents [104] . Among the studied 4thiazolidinones the pyrazole derivative 4.66 (Fig. 46 ) showed moderate effectiveness (IC 50 ¼ 10 mg/mL and EC 50 ¼ 70 mg/mL and cytotoxicity index CC 50 ¼ 90 mg/mL). (SI) > 16.3. In general, tested compounds had no antiviral activity against SARS CoV [97] . The screening was conducted for compounds ( Fig. 45) against Trypanosoma brucei brucei (Tbb) and Trypanosoma brucei gambiense (Tbg). The results showed moderate antitrypanosomal activity of compounds 4.67, 4.69 and 4.70 against both strains of tested parasites (activity indexes IC 50 (Tbb) ¼ 5.43e13.87 mM and IC 50 (Tbg) ¼ 2.53e6.66 mM) [97] .
Aiming to investigate the trypanocidal activity for pyrazolineethiazolidinone conjugates the synthesis of new 5-(pyrazolin-1-ylmethylene)-4-thiazolidinones was carried out (Fig. 48) . Target heterocycles were branched by the methylidene or oxoethylamino-methylidene linker groups. The results of screening against Trypanosoma brucei gambiense allowed to identify 5 compounds with sufficient antitrypanosomal activity (IC 50 has been directed on substitution of pyrazoline core and modification of N3-thiazolidinone position (4.73), elongation of linker group (4.74) and rhodanine-isorhodanine isomerism (4.75) [98] .
The study of antiparasitic activity for pyrazolineethiazolidinone 4.76 (Fig. 49 ) was carried out towars Trypanosoma cruzi, Trypanosoma b. rhodesiense, Leishmania donovani and Plasmodium falciparum. The results indicated a moderate inhibitory effect on Trypanosoma b. rhodesiense (IC 50 ¼ 12 mg/mL) and L. donovani (IC 50 > 30 mg/mL) and a higher influence on P. falciparum (IC 50 > 5 mg/mL) with cytotoxicity index CC 50 > 90 mg/mL [36] .
Design of new anti-inflammatory agents among pyrazoleethiazolidinones
The promising direction for pharmacological investigation of (Fig. 50) .
Detailed study of pyrazolineethiazolidinones as potential COX-1 and COX-2 inhibitors allowed to identify highly active compound 4.82 (IC 50 ¼ 0.5 mM for COX-2) with the best selective index (SI ¼ 84.8), which effectiveness was similar to that of Celecoxib. SAR analysis (Fig. 51 ) of the results showed the dependence of COX-2 inhibition on the nature of aryl substituents in the 3 (A-ring) and with the inhibition of ADAMTS-5 IC 50 ¼ 1.1 mM, that demonstrated a strong selectivity (SI > 40) compared to the inhibition of ADAMTS-4. Structural modification of substituents in the pyrazole moiety allowed to establish the main structural criteria to increase the inhibitory effect [83] .
Amal M. Youssef et al. carried out the synthesis of 5-((1,3-aryl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones as potential anti-inflammatory and neuroprotective agents [79] . The studies conducted in vitro and in vivo allowed to identify a group of highly active anti-inflammatory compounds with a low ulcerogenic impact and satisfactory toxicometry parameters. Based on in vitro experiments four compounds (4.89) were selected for in vivo studies according to screening protocols: the formalin-induced paw edema and turpentine oil-induced granuloma pouch bioassays. It was established that the tested compounds showed activity comparable to Celecoxib at a concentration of 20 mg/kg. The introduction of benzyl moiety in position 3 of thiazolidinone was accompanied by the loss of anti-inflammatory activity (Fig. 54 ).
Conclusions
This review article presents the rational approaches to the design of chemotherapeutic agents based on molecular hybridization of pharmacologically attractive thiazolidine and pyrazole/ pyrazoline heterocycles. Based on linkage of target heterocyclic cores the reviewed hybrids were classified as 2-, 3-and 5-pyrazole/ pyrazoline-substituted thiazolidines. The basic approaches for the synthesis of pyrazole-thiazolidinones have been provided by a combination of two "small" molecules via aminolysis, acylation reactions and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2þ3]-cyclization reaction yielding the series of non-condensed bicyclic systems. The review of biological applications was focused on SAR analysis and mechanistic insights of thiazolidineepyrazole hybrids. Molecular hybridization as a tool of medicinal chemistry has been successfully used for design of biologically active conjugates with antitumor activity, including inhibition of necroptosis, CDC25V phosphatase, TNF-aeTNFRc1 interaction or activation of pro-apoptotic BAX, antimicrobial, antifungal, antiviral and antiparasitic applications, as well as anti-inflammatory properties as inhibitors of COX or ADAMTS-5 enzymes.
Abbreviations
ADAMTS a disintegrin and metalloproteinase with thrombospondin motifs BAX
Bcl-2-associated X protein CC 50 half maximal cytotoxic concentration CDC25V dual-specificity phosphatase, the "cdc" in name refers to "cell division cycle" DCC dicyclohexylcarbodiimide DTP Development Therapeutics Program EC 50 half maximal effective concentration ED 50 half maximal effective dose IC 50 half maximal inhibitory concentration 
